PAMU
XLRN
Pictet Asset Management (UK)’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $84.2M | Buy |
671,041
+16,154
| +2% | +$2.03M | 0.09% | 256 |
|
|
2021
Q1 | $88.8M | Sell |
654,887
-132,493
| -17% | -$18M | 0.11% | 230 |
|
|
2020
Q4 | $101M | Buy |
787,380
+52,772
| +7% | +$6.75M | 0.13% | 197 |
|
|
2020
Q3 | $82.7M | Buy |
+734,608
| New | +$82.7M | 0.13% | 199 |
|
|
2019
Q2 | – | Sell |
-284,624
| Closed | -$13.3M | – | 1030 |
|
|
2019
Q1 | $13.3M | Buy |
284,624
+2,609
| +0.9% | +$122K | 0.03% | 459 |
|
|
2018
Q4 | $12.3K | Sell |
282,015
-138,565
| -33% | -$6.04K | 0.03% | 459 |
|
|
2018
Q3 | $24.1M | Sell |
420,580
-75,638
| -15% | -$4.33M | 0.05% | 371 |
|
|
2018
Q2 | $24.1M | Sell |
496,218
-19,855
| -4% | -$963K | 0.06% | 360 |
|
|
2018
Q1 | $20.2M | Buy |
516,073
+24,932
| +5% | +$975K | 0.05% | 377 |
|
|
2017
Q4 | $20.8M | Sell |
491,141
-138,666
| -22% | -$5.88M | 0.05% | 378 |
|
|
2017
Q3 | $23.5M | Sell |
629,807
-34,338
| -5% | -$1.28M | 0.07% | 337 |
|
|
2017
Q2 | $16.9M | Buy |
664,145
+15,612
| +2% | +$398K | 0.05% | 382 |
|
|
2017
Q1 | $17.2M | Buy |
648,533
+122,884
| +23% | +$3.25M | 0.06% | 377 |
|
|
2016
Q4 | $13.4M | Buy |
525,649
+55,543
| +12% | +$1.42M | 0.05% | 391 |
|
|
2016
Q3 | $17M | Sell |
470,106
-257,321
| -35% | -$9.31M | 0.06% | 346 |
|
|
2016
Q2 | $24.9M | Buy |
727,427
+641,327
| +745% | +$21.9M | 0.1% | 259 |
|
|
2016
Q1 | $2.18M | Hold |
86,100
| – | – | 0.01% | 682 |
|
|
2015
Q4 | $4.2M | Buy |
86,100
+24,400
| +40% | +$1.19M | 0.02% | 592 |
|
|
2015
Q3 | $1.54M | Buy |
61,700
+4,300
| +7% | +$107K | 0.01% | 745 |
|
|
2015
Q2 | $1.64M | Buy |
57,400
+5,800
| +11% | +$166K | 0.01% | 763 |
|
|
2015
Q1 | $1.43M | Sell |
51,600
-64,604
| -56% | -$1.79M | 0.01% | 780 |
|
|
2014
Q4 | $4.53M | Buy |
116,204
+70,604
| +155% | +$2.75M | 0.02% | 601 |
|
|
2014
Q3 | $1.38M | Buy |
45,600
+7,100
| +18% | +$215K | 0.01% | 772 |
|
|
2014
Q2 | $1.31M | Buy |
+38,500
| New | +$1.31M | 0.01% | 769 |
|